Oruka Therapeutics (ORKA) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -12.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.98% |
| Dec 31, 2025 | -20.15% |
| Sep 30, 2025 | 22.35% |
| Jun 30, 2025 | -109.65% |
| Mar 31, 2025 | -12,322.02% |
| Dec 31, 2024 | -1,682.01% |
| Sep 30, 2024 | -1,566.75% |
| Jun 30, 2024 | -1,489.77% |
| Mar 31, 2024 | 89.47% |
| Dec 31, 2023 | 29.32% |
| Sep 30, 2023 | 33.19% |
| Jun 30, 2023 | 73.53% |
| Mar 31, 2023 | 62.89% |
| Dec 31, 2022 | 69.80% |
| Sep 30, 2022 | 48.71% |
| Jun 30, 2022 | 29.52% |
| Mar 31, 2022 | 17.74% |
| Dec 31, 2021 | -65.18% |
| Sep 30, 2021 | -143.26% |
| Jun 30, 2021 | -257.01% |
| Mar 31, 2021 | -209.91% |
| Dec 31, 2020 | -158.64% |
| Sep 30, 2020 | -125.70% |
| Jun 30, 2020 | 12.44% |
| Mar 31, 2020 | -7.66% |
| Dec 31, 2019 | 13.78% |
| Sep 30, 2019 | 43.72% |
| Jun 30, 2019 | 47.20% |
| Mar 31, 2019 | 49.01% |
| Dec 31, 2018 | 67.99% |
| Sep 30, 2018 | 60.34% |
| Jun 30, 2018 | 54.54% |
| Mar 31, 2018 | 29.30% |
| Dec 31, 2017 | -9.21% |
| Sep 30, 2017 | -6.37% |
| Jun 30, 2017 | -40.61% |
| Mar 31, 2017 | -11.87% |
| Dec 31, 2016 | -46.64% |
| Sep 30, 2016 | -55.54% |
| Jun 30, 2016 | -46.98% |
| Mar 31, 2016 | -24.73% |
| Dec 31, 2015 | -39.44% |
| Sep 30, 2015 | -15.65% |
| Jun 30, 2015 | -36.07% |
| Mar 31, 2015 | 15.57% |
| Dec 31, 2014 | -0.37% |
| Sep 30, 2014 | -23.93% |
| Jun 30, 2014 | -80.64% |
| Mar 31, 2014 | -382.59% |
| Dec 31, 2013 | -179.40% |
| Sep 30, 2013 | -116.26% |
| Jun 30, 2013 | 0.10% |
| Mar 31, 2013 | 53.86% |
| Dec 31, 2012 | 45.79% |
| Sep 30, 2012 | 53.76% |
| Jun 30, 2012 | 53.63% |
| Mar 31, 2012 | 14.64% |
| Dec 31, 2011 | -8.23% |
| Sep 30, 2011 | 16.70% |